DR. AJAY GUPTA

Assistant Professor


Pharmacology
MBBS, MD, DNB
PMC - 62873

About Doctor

Dr Ajay Gupta MD, DNB (Pharmacology) is Assistant Professor in the Department of Pharmacology. He has been awarded the membership of National Academy of Medical Sciences (MNAMS) & is also a life member of National Association of Pharmacology & Therapeutics. He has twelve publications in international and national journals and also authored a book chapter. An alumnus of AMU Aligarh and ex senior resident of AIIMS, Jodhpur, he is a peer reviewer of many national and international journals including British Journal of Clinical Pharmacology. He has received number of awards including essay writing competition, quiz competition and poster presentation. He has attended numerous conferences and hands on workshops and has vast experience in diverse areas of Pharmacology including Research Methodology, Pharmacovigilance, Experimental Pharmacology, Good Clinical Practices and Ethical practices in conducting clinical trials. He is actively involved in UG & PG training, activities related to hospital infection prevention and control. His areas of interest include clinical and molecular pharmacology.

Specialization and Expertise

Pharmacology

Certifications

  • Life member, National Medicos Organization (NMO) since May 2016.
  • Member , National Academy of Medical Sciences (MNAMS) since 2017.
  • Life member, National Association of Pharmacology and Therapeutics (NPT) since 2023.

Publications

  •  Gupta A, Rahman SZ. Pharmacoenvironmentology and Environmental risk: Current status. J Pharmacovig Drug Safety. 2015;12(1):49-51.
  • Gupta A, Sharma PK, Misra AK, Singh S. Lesinurad: A significant advancement or just another addition to existing therapies of gout?. Journal of pharmacology & pharmacotherapeutics. 2016 Oct;7(4):155.
  • Misra A, Gupta A, Tank N, Kaklotar D, Singh S, Sharma P. Pharmacotherapy in metabolic syndrome. J. Ration. Pharm. 2017;3(1):20-37.
  •  Sharma PK, Misra AK, Gupta N, Khera D, Gupta A, Khera P. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun. Indian J Pharmacol 2017;49:390-5.
  • Sharma PK, Misra AK, Gupta A, Singh S, Dhamija P, Pareek P. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence. Indian J Pharmacol 2018;50:273-8.
  • Sharma PK, Singh S, Misra AK, Singh V, Midha NK, Kumar B, Gupta A*. Efficacy, Safety and Cost-effectiveness Comparison of Rosuvastatin 5mg with Atorvastatin 20mg in Hypercholesterolaemic Patients: A Prospective Open Label Clinical Study. Adv Clin Endo Met. 2018;1(1): 07-15.        
  • Gupta A, Jain S, Gupta V. Viral RNA Shedding and Transmission Potential of Asymptomatic and Pauci-symptomatic COVID-19 Patients. In Open Forum Infectious Diseases 2021 Aug 1 (Vol. 8, No. 8, p. ofab112). US: Oxford University Press.
  • Kumar R, Misra AK, Dutta S, Gupta A, Kumar B, Charan J. A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids?. Journal of Family Medicine and Primary Care. 2022 Jun 1;11(6):2573-80.

Awards

  •  Awarded 3rd prize in the Quiz Competition held during National CME on Pharmacotherapy Update in Common Medical Disorders – A rational Approach from 1st -2nd November 2014 held at Aligarh.
  •  Awarded 1st prize for poster presentation on the topic “Pharmacoenvironmentology and Environmental Risk: Current status” at XIII Annual conference and International Symposium SOPI, India from 22nd -24th November 2013 held at Anand Gujarat.
  • Awarded 1st prize in essay competition on the topic Recent Advances in the Diagnosis of Tuberculosis held on the occasion of World Tuberculosis Day 2007.


logo